Recent News

• 03.18.2025 - MiNK Therapeutics Fourth Quarter 2024 Financial Results
• 03.18.2025 - MiNK Therapeutics Fourth Quarter 2024 Financial Results
• 03.18.2025 - MiNK Therapeutics Reports Fourth Quarter & Full Year 2024 Results and Highlights Business Progress
• 03.18.2025 - MiNK Therapeutics Reports Fourth Quarter & Full Year 2024 Results and Highlights Business Progress
• 03.04.2025 - MiNK Therapeutics to Provide Corporate Update and Fourth Quarter & Full Year 2024 Financial Report
• 03.04.2025 - MiNK Therapeutics to Provide Corporate Update and Fourth Quarter & Full Year 2024 Financial Report
• 02.24.2025 - MiNK Therapeutics Presents First-in-Kind Allo-iNKTs Combination Data in 2L Gastric Cancer at AACR IO Annual Meeting
• 02.24.2025 - MiNK Therapeutics Presents First-in-Kind Allo-iNKTs Combination Data in 2L Gastric Cancer at AACR IO Annual Meeting
• 02.20.2025 - MiNK Therapeutics Regains Full Compliance with Nasdaq Listing Requirements
• 02.20.2025 - MiNK Therapeutics Regains Full Compliance with Nasdaq Listing Requirements

Recent Filings

• 03.18.2025 - 8-K Current report
• 03.18.2025 - EX-99.1 EX-99.1
• 03.18.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.05.2025 - 4 Statement of changes in beneficial ownership of securities